Molina Healthcare (MOH) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Molina Healthcare

NYSE•Healthcare•Healthcare Plans

$204.78+5.83(0.03%)Market closed

Market Cap

$10.67B

P/S

0.2x

P/B

2.6x

Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates through Medicaid, Medicare, Marketplace, and Other segments. The company was founded in 1980 and is headquartered in Long Beach, California.

How this company scores

AverageMetricSide Score: 42/100

Strongest: Balance Sheet & Red Flags (17/25); weakest: Growth (8/25).

Profitability8/25

Growth8/25

Balance Sheet & Red Flags17/25

Cash & Earnings Quality9/25

Strengths

Long cash runwayNet cash positionNo share dilution

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 35.6x5y range 11.5x – 35.6x

Currently above its 18-quarter median.

P/S · 0.2x5y range 0.1x – 0.7x

Currently below its 20-quarter median.

P/B · 2.6x5y range 1.6x – 7.1x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

Operating margins dropped 86.3% over recent quarters — a sharp decline suggesting serious cost or pricing challenges.

Earnings Quality

Red Flag

Free cash flow has been negative in 6 of the last 8 quarters — earnings are not translating to cash.

Price & Volume

Market Cap $10.67B

Metrics at a Glance

as of September 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $44.13B
Q. Revenue: $11.08B
TTM EBITDA: $333.00M
TTM Op. Income: $172.00M
Q. Op. Income: $106.00M
TTM Net Income: $-48.00M
Q. Net Income: $38.00M
EPS: $0.74
Shares Out.: $51.20M

$44.13B in TTM revenue declined 0.9% YoY, reaching $11.08B last quarter. TTM EBITDA of $333.00M and TTM operating income of $172.00M show growth is flowing through to the bottom line. However, net income is negative at $48.00M — growth is not yet reaching the bottom line. Across the last 8 quarters, TTM revenue has fallen for 3 consecutive quarters — a weakening trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 12.3%
EBITDA Margin: 1.3%
Op. Margin: 1.0%
Net Margin: 0.3%

Op. margin of 1.0% is down 0.2% YoY — costs are rising relative to revenue. Net margin at 0.3% and gross margin of 12.3% show how much of each revenue dollar survives to profit. Over the past year, operating margin is down 20% — a weakening trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: N/A
P/S Ratio: 0.2x
P/B Ratio: 2.6x

P/S of 0.2x and P/B of 2.6x. P/S is low relative to typical market levels. Across the last 6 quarters, P/E has risen for 2 consecutive quarters — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $15.65B
Cash: $4.48B
Long-Term Debt: $3.77B
Book Value: $4.16B
D/E Ratio: 0.9
Debt/EBITDA: 26.2

With $15.65B in assets and $3.77B in long-term debt, D/E is 0.9and book value is $4.16B — a conservative capital structure with a cushion to weather downturns. Over the past year, debt/equity is up 4% — a weakening trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $-159.00M
TTM Free Cash Flow: $238.00M
FCF Margin: 0.5%
FCF / Net Income: -5.0

TTM FCF of $238.00M on $-159.00M in operating cash flow. The FCF / Net Income ratio of -5.0x means the business consumes cash — it is not yet self-funding. Over the past year, free cash flow is up 141% — a weakening trend.